The link between COVID-19 infection and development of autoimmune disease is becoming more pronounced, and fields including dermatology are seeking answers to what drives it all.

A late-breaking session at the American Academy of Dermatology (AAD) 2022 Annual Meeting this weekend showed patients infected with SARS-CoV-2 are a heightened risk of developing cutaneous autoimmune and vascular conditions.

The findings, presented by Brigham and Women’s Hospital clinical fellow of medicine Zachary Holcomb, MD, showed what he told HCPLive is a definite signal triggering various autoimmune disease risks following infection of the pandemic virus.

Specifically, Holcomb said in an interview, systemic diseases appear to be “quite prevalent” after COVID-19.

Read More